Enovis Corp (ENOV) Stock Price, Quote & News

Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic sho...

Industry: Medical Devices

Sector: Healthcare

Phone: 302 252 9160

Website: www.enovis.com

Address:

2711 Centerville Road, Suite 400, Wilmington, United States

stockRDA Dec. 5 at 8:20 PM

$ENOV i smell a buy out…..

0 · Reply

stockRDA Dec. 1 at 9:17 PM

$ENOV I smell a buyout……..

0 · Reply

JarvisFlow Nov. 7 at 6:51 PM

Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 41 → 42.

0 · Reply

d_risk Nov. 6 at 4:12 PM

$ENOV - Enovis Corporation Common Stock - 10Q - Updated Risk Factors ENOV warns that further impairment of intangible assets, including goodwill, could hit operating results and total capitalization. #HealthcareSector #CapitalizationRisk #OperatingResultsImpact #GoodwillRisk #IntangibleAssetImpairment 🟢 Added 🟠 Removed https://d-risk.ai/ENOV/10-Q/2025-11-06

0 · Reply

DonCorleone77 Nov. 6 at 11:35 AM

$ENOV Enovis reports Q3 adjusted EPS 75c, consensus 65c -- Q3 revenue $549M, consensus $538.61M. -- Raises FY25 adjusted EPS view to $3.10-$3.25 from $3.05-$3.20, consensus $3.13.

0 · Reply

nikitatrades Oct. 15 at 9:03 AM

💼 Enovis $ENOV sells its Dr. Comfort diabetic shoe business for up to $60M. The divestiture allows the company to sharpen its focus on its core Prevention & Recovery segment.

0 · Reply

stockRDA Oct. 11 at 1:51 AM

$ENOV good cheap company. Will buy more if this name drops next week.

0 · Reply

nikitatrades Oct. 8 at 8:00 PM

Strategic move for $ENOV: 💼 Sells Dr. Comfort business for up to $60M. Sharpens focus on core Prevention & Recovery. Enhances margins and accelerates debt paydown.

0 · Reply

jabber621 Sep. 22 at 5:07 PM

$ENOV can someone remind why I am invested here?

0 · Reply

RalphThomas530 Sep. 21 at 11:01 AM

$ENOV Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum.

0 · Reply

Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 6, 2025, 8:26 PM EST - 4 weeks ago

Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 6:01 AM EST - 4 weeks ago

Enovis Announces Third Quarter 2025 Results

Oct 24, 2025, 4:11 PM EDT - 6 weeks ago

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

Oct 8, 2025, 8:15 AM EDT - 2 months ago

Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million

Sep 8, 2025, 4:05 PM EDT - 3 months ago

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Aug 27, 2025, 8:24 AM EDT - 3 months ago

Enovis: Healthy Recon Trends Vs. Market Apathy

Aug 8, 2025, 9:00 AM EDT - 4 months ago

Enovis to Participate in Upcoming Investor Conferences

Aug 8, 2025, 3:25 AM EDT - 4 months ago

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:32 AM EDT - 4 months ago

Enovis (ENOV) Q2 Revenue Rises 7%

Aug 7, 2025, 6:00 AM EDT - 4 months ago

Enovis Announces Second Quarter 2025 Results

Jul 8, 2025, 4:05 PM EDT - 5 months ago

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

May 26, 2025, 10:46 AM EDT - 6 months ago

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

May 11, 2025, 1:46 AM EDT - 7 months ago

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:00 AM EDT - 7 months ago

Enovis Announces First Quarter 2025 Results

Apr 17, 2025, 7:00 AM EDT - 8 months ago

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Apr 2, 2025, 6:30 AM EDT - 8 months ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Mar 25, 2025, 8:00 AM EDT - 9 months ago

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Feb 28, 2025, 8:23 AM EST - 10 months ago

Enovis Continues To Languish Despite Decent Financial Results

Feb 26, 2025, 12:53 PM EST - 10 months ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 6:01 AM EST - 10 months ago

Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:00 AM EST - 10 months ago

Enovis Announces Planned CEO Succession Process

Jan 17, 2025, 6:00 AM EST - 11 months ago

Enovis™ Announces Leadership Change to International Surgical Business

Jan 7, 2025, 6:19 PM EST - 11 months ago

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Jan 6, 2025, 4:15 PM EST - 11 months ago

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Nov 22, 2024, 12:17 PM EST - 1 year ago

Enovis Corporation: Reasonably Valued With Caveats

Nov 6, 2024, 12:50 PM EST - 1 year ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2024 Results

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Oct 3, 2024, 3:39 PM EDT - 1 year ago

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Sep 9, 2024, 3:50 PM EDT - 1 year ago

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Aug 20, 2024, 8:00 AM EDT - 1 year ago

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results

Jul 25, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Jul 16, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Jul 15, 2024, 12:58 AM EDT - 1 year ago

Enovis Languishing Despite Respectable Performance

Jul 12, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN

May 2, 2024, 2:24 PM EDT - 1 year ago

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

May 2, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces First Quarter 2024 Results

Apr 17, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Feb 22, 2024, 12:14 PM EST - 1 year ago

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 12, 2024, 11:30 AM EST - 1 year ago

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Feb 7, 2024, 4:15 PM EST - 1 year ago

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 26, 2024, 6:00 AM EST - 2 years ago

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Jan 25, 2024, 8:30 AM EST - 2 years ago

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Jan 3, 2024, 6:00 AM EST - 2 years ago

Enovis Completes Acquisition of LimaCorporate S.p.A

Dec 28, 2023, 5:00 AM EST - 2 years ago

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

stockRDA Dec. 5 at 8:20 PM

$ENOV i smell a buy out…..

0 · Reply

stockRDA Dec. 1 at 9:17 PM

$ENOV I smell a buyout……..

0 · Reply

JarvisFlow Nov. 7 at 6:51 PM

Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 41 → 42.

0 · Reply

d_risk Nov. 6 at 4:12 PM

0 · Reply

DonCorleone77 Nov. 6 at 11:35 AM

$ENOV Enovis reports Q3 adjusted EPS 75c, consensus 65c -- Q3 revenue $549M, consensus $538.61M. -- Raises FY25 adjusted EPS view to $3.10-$3.25 from $3.05-$3.20, consensus $3.13.

0 · Reply

nikitatrades Oct. 15 at 9:03 AM

💼 Enovis $ENOV sells its Dr. Comfort diabetic shoe business for up to $60M. The divestiture allows the company to sharpen its focus on its core Prevention & Recovery segment.

0 · Reply

stockRDA Oct. 11 at 1:51 AM

$ENOV good cheap company. Will buy more if this name drops next week.

0 · Reply

nikitatrades Oct. 8 at 8:00 PM

Strategic move for $ENOV: 💼 Sells Dr. Comfort business for up to $60M. Sharpens focus on core Prevention & Recovery. Enhances margins and accelerates debt paydown.

0 · Reply

jabber621 Sep. 22 at 5:07 PM

$ENOV can someone remind why I am invested here?

0 · Reply

RalphThomas530 Sep. 21 at 11:01 AM

$ENOV Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum.

0 · Reply

stockRDA Sep. 18 at 12:40 AM

$ENOV anybody here? I like this business.

0 · Reply

SocioCobb Sep. 12 at 3:29 AM

$ENOV

0 · Reply

CEOBuysDisclosures Sep. 12 at 12:05 AM

$ENOV CEO purchased 6,457 shares at $30.97 for a total of $199,973. McDonald Damien now owns 102,753 shares. https://ceo-buys.com

0 · Reply

NVDAMillionaire Sep. 4 at 10:24 AM

$ENOV Great piece that accurately captures ENOV's current position. So if you want to refresh your understanding of ENOV or learn about ENOV for the first time, this is essential reading. https://beyondspx.com/quote/ENOV/enov-forging-a-medtech-future-growth-margins-and-innovation-post-transformation#analysis

1 · Reply

ZacksResearch Sep. 2 at 11:52 PM

Tired of the “Magnificent Seven”? Zacks highlights small & mid-cap stocks trading 50%+ below target with “Buy” ratings: $ENOV $NEXN $ROOT $IAS $ARQT Big upside potential 👀 #StocksToBuy #ZacksRank #Investing https://www.zacks.com/featured-articles/101/best-stocks-to-buy-now

0 · Reply

QuantumFinanceCapital Aug. 23 at 1:26 PM

$ENOV Enovis Corporation is facing medical device adoption challenges and acquisition integration

0 · Reply

StockHunter75 Aug. 22 at 2:48 PM

$ENOV going to run to 35+ load up

0 · Reply

StockHunter75 Aug. 22 at 2:47 PM

$ENOV Bullish.

0 · Reply

JarvisFlow Aug. 8 at 9:30 PM

Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 70 → 58.

0 · Reply

JarvisFlow Aug. 8 at 6:36 PM

UBS has updated their rating for Enovis ( $ENOV ) to Buy with a price target of 57.

0 · Reply

JarvisFlow Aug. 8 at 3:19 PM

Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 48 → 41.

0 · Reply

JarvisFlow Aug. 8 at 10:00 AM

Needham updates rating for Enovis ( $ENOV ) to Buy, target set at 57 → 49.

0 · Reply

Market Cap	1.68B
Revenue (ttm)	2.11B
Net Income (ttm)	-825.49M
EPS (ttm)	N/A
PE Ratio	8.82
Forward PE	9.25
Profit Margin	-39.17%
Debt to Equity Ratio	0.67

Volume	1,531,309
Avg Vol	735,864
Day's Range	N/A - N/A
Shares Out	57.19M
Stochastic %K	61%
Beta	1.52
Analysts	Strong Sell
Price Target	$48.11